ScoreWhy is Titan Biotech Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.04 times
2
Poor long term growth as Operating profit has grown by an annual rate -7.23% of over the last 5 years
3
Positive results in Sep 25
- NET SALES(Q) At Rs 54.35 cr has Grown at 36.25%
- PBDIT(Q) Highest at Rs 9.32 cr.
- PBT LESS OI(Q) Highest at Rs 7.90 cr.
4
With ROE of 13.9, it has a Very Expensive valuation with a 4.9 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 20.08%, its profits have fallen by -8.8%
5
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
6
Consistent Returns over the last 3 years
- Along with generating 20.08% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Titan Biotech should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Titan Biotech for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Titan Biotech
437.83%
0.34
59.94%
Sensex
-4.3%
0.43
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.72%
EBIT Growth (5y)
-6.32%
EBIT to Interest (avg)
26.27
Debt to EBITDA (avg)
0.26
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
1.22
Tax Ratio
25.09%
Dividend Payout Ratio
6.65%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
25.43%
ROE (avg)
21.23%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
77
Industry P/E
37
Price to Book Value
12.51
EV to EBIT
71.99
EV to EBITDA
62.38
EV to Capital Employed
12.16
EV to Sales
10.84
PEG Ratio
3.66
Dividend Yield
0.08%
ROCE (Latest)
13.46%
ROE (Latest)
13.86%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend28What is working for the Company
PBT LESS OI(Q)
Highest at Rs 9.30 cr.
NET SALES(Q)
Highest at Rs 56.51 cr
PBDIT(Q)
Highest at Rs 10.84 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 19.18%
PAT(Q)
Highest at Rs 8.53 cr.
EPS(Q)
Highest at Rs 10.33
-3What is not working for the Company
ROCE(HY)
Lowest at 16.04%
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.88 times
Loading Valuation Snapshot...
Here's what is working for Titan Biotech
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 9.30 cr has Grown at 164.96%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 8.53 cr has Grown at 94.3%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
At Rs 56.51 cr has Grown at 47.62%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 9.30 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
Highest at Rs 56.51 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 10.84 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 19.18%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit After Tax (PAT) - Quarterly
Highest at Rs 8.53 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 10.33
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Titan Biotech
Debtors Turnover Ratio- Half Yearly
Lowest at 5.88 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
